These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33585159)

  • 1. Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies.
    Sholler DJ; Schoene L; Spindle TR
    Curr Addict Rep; 2020 Sep; 7(3):405-412. PubMed ID: 33585159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
    Koturbash I; MacKay D
    J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol: pharmacology and therapeutic targets.
    Britch SC; Babalonis S; Walsh SL
    Psychopharmacology (Berl); 2021 Jan; 238(1):9-28. PubMed ID: 33221931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Cannabidiol on Psychiatric and Medical Conditions.
    Oberbarnscheidt T; Miller NS
    J Clin Med Res; 2020 Jul; 12(7):393-403. PubMed ID: 32655732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
    White CM
    J Clin Pharmacol; 2019 Jul; 59(7):923-934. PubMed ID: 30730563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review.
    Balachandran P; Elsohly M; Hill KP
    J Gen Intern Med; 2021 Jul; 36(7):2074-2084. PubMed ID: 33515191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Status of Cannabidiol in the United States: A Perspective.
    Corroon J; Kight R
    Cannabis Cannabinoid Res; 2018; 3(1):190-194. PubMed ID: 30283822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science.
    Marinotti O; Sarill M
    J Diet Suppl; 2020; 17(5):517-526. PubMed ID: 32543253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicians' Guide to Cannabidiol and Hemp Oils.
    VanDolah HJ; Bauer BA; Mauck KF
    Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Adverse Effects and Toxicity.
    Huestis MA; Solimini R; Pichini S; Pacifici R; Carlier J; Busardò FP
    Curr Neuropharmacol; 2019; 17(10):974-989. PubMed ID: 31161980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children.
    Singer L; Tokish H; Park F; Campisi C; Milanaik RL
    Curr Opin Pediatr; 2020 Feb; 32(1):198-205. PubMed ID: 31833952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid therapy in epilepsy.
    Billakota S; Devinsky O; Marsh E
    Curr Opin Neurol; 2019 Apr; 32(2):220-226. PubMed ID: 30676535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can cannabidiol (CBD) help with low back pain?
    Kulesza B; Mazurek M; Kurzepa J
    Ann Agric Environ Med; 2023 Sep; 30(3):549-554. PubMed ID: 37772533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
    Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L
    Lancet Psychiatry; 2019 Dec; 6(12):995-1010. PubMed ID: 31672337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.